Pricing Log in Create free account

Biorestorative Therapies, Inc. (BRTX) vs Revelation Biosciences, Inc. (REVB)

Biorestorative Therapies, Inc. and Revelation Biosciences, Inc. are both Biotechnology companies. Biorestorative Therapies, Inc. and Revelation Biosciences, Inc. are of similar size ($2.1M and $2.0M). Revelation Biosciences, Inc. has the higher net margin (0.00% vs −3,089.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Revelation Biosciences, Inc. leads on 7 and Biorestorative Therapies, Inc. on 6.

Valuation

Metric BRTX REVB Biotechnology median
P/E n/m n/m 10.60
P/S 3.67 n/m 9.40
P/B 0.43 0.20 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.15 0.84 0.66
EV/Sales (5.84) n/m 9.02
Earnings yield (1,445.95%) (2,328.22%) (32.88%)
Free cash flow yield (999.27%) (466.23%) (23.13%)

Profitability

Metric BRTX REVB Biotechnology median
Gross margin 92.09% 0.00% 68.51%
Operating margin (3,974.66%) 0.00% 0.00%
Net margin (3,089.30%) 0.00% 0.00%
Free cash flow margin (3,302.04%) 0.00% 0.00%
Return on equity (241.50%) (276.43%) (51.96%)
Return on assets (147.75%) (214.63%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BRTX REVB Biotechnology median
Revenue growth (TTM) (8.47%) — 6.76%
EPS growth (last fiscal year) (36.21%) 97.72% 29.88%
Revenue growth, 5-year CAGR 36.11% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BRTX REVB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.35 6.21 4.97
Net debt to EBITDA 0.19 1.18 1.01

Dividend

Metric BRTX REVB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BRTX REVB Biotechnology median
Market cap 2.09m 2.02m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack